Connection

Gregory Cote to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Gregory Cote has written about Drug Resistance, Neoplasm.
Gregory Cote
Connection Strength
0.355
Drug Resistance, Neoplasm
  1. NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function. Br J Pharmacol. 2016 Feb; 173(3):613-26.
    View in: PubMed
    Score: 0.107
  2. A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells. BMC Cancer. 2014 Sep 19; 14:681.
    View in: PubMed
    Score: 0.098
  3. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925. Br J Cancer. 2014 Jun 10; 110(12):2896-904.
    View in: PubMed
    Score: 0.096
  4. Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells. Oncotarget. 2017 May 02; 8(18):30276-30287.
    View in: PubMed
    Score: 0.029
  5. NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. Gynecol Oncol. 2015 Apr; 137(1):134-42.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.